National Symposium 2016

323 - Pharmacogenomics

May 4, 2016 10:45am ‐ May 4, 2016 12:00pm


Credits: None available.

Standard: $40.00
Members: $30.00

Description

Describe the background and relevance of pharmacogenomics and the implications for care for the patient with CKD.

Contact hours available until 5/4/18.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Denise Murcek – Employee, Fresenius Medical Care
• Dawn Koonkongsatian – Employee, Fresenius Medical Care
• Melissa Nesmith-Vester – Employee, Aegerion
• Elizabeth St. John - Employee, Fresenius Medical Care
• Kyra Trappett – Employee, DaVita
• Kimberly Waugh – Employee, Fresenius Medical Care

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Objectives:
• Describe the background and relevance of pharmacogenomics.
• Examine the four rights of pharmacogenomics.
• Discuss the implications for care for the patient with CKD in regard to pharmacogenomics.

Speaker(s):

Credits Available


You must be logged in and own this session in order to post comments.